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Abstract 
Over the last two decades, treatment guidelines have become major aids to the delivery of 
evidence-based care and to improve clinical outcomes.  The International Society for 
Traumatic Stress Studies (ISTSS) produced the first guidelines for the prevention and 
treatment of posttraumatic stress disorder (PTSD) in 2000 and published its latest 
recommendations, along with position papers on Complex PTSD, in November 2018.  A 
rigorous methodology was developed and followed; scoping questions were posed, 
systematic reviews were undertaken and 361 randomized controlled trials were included 
according to the a priori agreed inclusion criteria.  Two hundred and eight meta-analyses 
were conducted and used to generate 125 recommendations (24 for children and adolescents, 
and 101 for adults) for specific prevention and treatment interventions, using an agreed 
definition of clinical importance and recommendation setting algorithm. There were 8 Strong, 
8 Standard, 5 Low Effect, 26 Emerging Evidence, and 78 Insufficient Evidence to 
Recommend recommendations. Inclusion of separate scoping questions on treatments for 
complex presentations of PTSD was considered but decided against due to definitional issues 
and the virtual absence of studies specifically designed to clearly answer possible scoping 
questions in this area. Narrative reviews were undertaken and position papers prepared (one 
for children and adolescents, and one for adults) to consider the current issues around 
Complex PTSD and make recommendations to facilitate further research. This paper 
describes the methodology and results of the ISTSS Guideline process and considers the 
interpretation and implementation of the recommendations.  
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The ISTSS Guidelines for the Prevention and Treatment of PTSD 
Keeping on top of the proliferation of evidence regarding the prevention and 
management of health conditions has become a major challenge.  As a result, healthcare 
professionals, policy makers and service planners along with those seeking or using services, 
increasingly rely on syntheses of available evidence to inform what should be provided and 
sought.  Guidelines, developed through syntheses of evidence, are now widely advocated and 
followed.  The International Society of Traumatic Stress Studies (ISTSS) produced the first 
guidelines for the prevention and treatment of posttraumatic stress disorder (PTSD) in 2000
(Foa et al., 2000) and updated these in 2009 (Foa et al., 2009). The goal of this paper is to 
describe the development and facilitate the interpretation of the third version of the ISTSS 
Guidelines for the Prevention and Treatment of PTSD (ISTSS, 2018). 
Determining how to interpret and implement guidelines in real-life settings can be 
difficult (Shekelle, 2018) and is made more complicated by different guidelines for the same 
condition drawing different conclusions.  The prevention and treatment of PTSD is a good 
example of this, with a number of guidelines from reputable sources (e.g. the UK’s National 
Institute for Health and Care Excellence (NICE, 2005), American Psychological Association 
(APA, 2017), US Veterans Affairs/Department of Defense (VA/DoD, 2017), Phoenix 
Australia (2013), and the ISTSS providing overlapping but non-identical recommendations in 
recent years (Forbes et al., 2010; Hamblen et al., 2018).  The unavoidable conclusion is that 
guideline development is an imprecise science, with multiple degrees of freedom in the 
process, and the subsequent clinical recommendations may vary depending on the 
methodology used.  This situation has resulted in calls for greater standardization of guideline 
development and a more harmonious approach among guideline developers in the future 
(IoM, 2011).  
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It is widely advocated that guideline developers rely on systematic reviews of 
research evidence with quality and strength of evidence being taken into account before 
determining how strongly to recommend a particular intervention (IoM, 2011; GRADE, 
2018).  This has, inevitably, led to the adoption of a hierarchy of evidence. Most such 
hierarchies consider randomized controlled trials (RCTs) the gold standard to determine what 
does and does not work (Eccles & Mason, 2001).  Critics argue, however, that potentially 
important evidence generated outside RCTs is ignored and can devalue the recommendations 
made (Henriques, 2018).  This concern echoes the sentiments of the founders of evidence-
based practice who said, “Good healthcare professionals use both individual clinical expertise 
and the best available external evidence, and neither alone is enough.” (Sackett et al., 1996).  
Taking a more inclusive approach to evidence sources offers the opportunity to 
include treatment approaches that have not been subjected to randomized controlled trials. 
However, this approach also comes with costs. The interpretation and comparison of results 
from different research designs is complicated and risks interventions that lack robust 
evidence being recommended more strongly than they should be.  The inferences that can be 
drawn from study designs other than a well-controlled RCT may be very biased and, 
therefore, not yield sufficient information to make evidence-based recommendations.  The 
first two versions of the ISTSS Guidelines took a more inclusive approach to the evidence 
and recommendations were based on methodologically variable reviews of the literature by 
individuals with an interest in a particular topic area.  Although this reflected common 
practice at the time, this approach is inconsistent with current standards and can be criticized 
for not adopting a priori decision rules that are objectively applied. More recent PTSD 
guidelines have adopted a more standardized methodology (e.g. NICE, 2018; APA, 2017; 
Phoenix Australia, 2013; VA/DoD, 2017; WHO, 2013) whereby specific questions were 
ISTSS Guidelines for PTSD  4 
 
 
developed and independent systematic reviews undertaken to answer them, with experts 
following more formal processe  to determine final recommendations.   
With this backdrop, in 2015, the ISTSS Board of Directors decided to update its 
prevention and treatment guidelines for PTSD.  It sought to generate guidelines through a 
robust methodological process that would be helpful to the traumatic stress field. The 
resulting guidelines will provide practitioners, service planners, policy-makers, people with 
li ved experience of PTSD and other relevant stakeholders with accurate information on what 
works and what does not work to prevent or treat PTSD.  This effort resulted in the 
publication of the ISTSS Guidelines for the Prevention and Treatment of PTSD 
recommendations and position papers in November 2018 (ISTSS, 2018).  These publications 
will be complemented by the final part of the updated ISTSS Guidelines, the third edition of 
the “Effective Treatments for PTSD” book, due to be published at the end of 2019, with a 
primary goal of providing a resource for clinicians to apply the recommendations to clinical 
practice.   
Method 
The ISTSS Board appointed an ISTSS Guidelines Committee (the authors of this 
paper) to develop its guidelines. The committee adopted a methodology that involved three 
distinct steps: (1) development of scoping questions to guide the review, (2) systematic 
reviews of the literature to identify RCTs that could answer the a priori scoping questions and 
(3) meta-analyses of usable data from the included studies to allow the generation of 
recommendations for prevention and treatment interventions.   
Scoping Questions 
The Committee agreed on draft scoping questions in a Population, Intervention, 
Comparator, and Outcomes (PICO; Schardt et al., 2007) format for the prevention and 
treatment of PTSD in children, adolescents and adults (e.g., “For adults with PTSD, do 
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psychological treatments, when compared to treatment as usual, waiting list or no treatment, 
result in a clinically important reduction of symptoms, improved functioning/quality of life, 
presence of disorder, or adverse effects?”). Separate draft scoping questions were developed 
to address the prevention or treatment of PTSD (clinically relevant posttraumatic stress 
symptoms in the case of children and adolescents).  The committee consulted on the draft 
scoping questions with the ISTSS membership and reference groups of practitioners and non-
practitioner consumers for feedback before presentation to and approval by the ISTSS Board.  
Inclusion of separate scoping questions on treatments for complex presentations of 
PTSD for children/adolescents and adults was considered but decided against due to issues 
defining Complex PTSD (CPTSD) and the virtual absence of studies specifically designed to 
clearly answer possible scoping questions in this area.  The Committee decided, therefore, to 
undertake a narrative review and prepare position papers (one for children and adolescents, 
and one for adults) to consider the current issues around CPTSD and make recommendations 
to facilitate further research.   
Systematic Reviews and Meta-Analyses 
High quality systematic reviews developed by the Cochrane Collaboration, NICE and 
the WHO were identified that addressed all the scoping questions except those pertaining to 
non-psychological and non-pharmacological interventions.  RCTs included in these reviews 
were used as the basis of the evidence to be considered for the ISTSS guidelines.  Existing 
reviews (Rose et al., 2005; Roberts et al., 2009; Roberts et al., 2010; Bisson et al., 2013; 
Hoskins et al., 2015; Sijbrandij et al., 2015; Lewis et al., 2015; NICE, 2018) were 
supplemented with additional systematic searches for more recent RCTs, and by asking 
experts in the field as well as the ISTSS membership to identify any studies that might have 
been omitted.  New systematic reviews were undertaken for the non-psychological and non-
pharmacological scoping questions. The Cochrane Collaboration Mental Health Disorders 
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Group completed additional searches using their comprehensive search strategies, to identify 
RCTs of any intervention designed to prevent or treat PTSD that were published during the 
period 1 January 2008 to 31 March 2018.   
Studies included in existing systematic reviews and newly identified studies were 
assessed against the inclusion criteria agreed upon for the ISTSS Guidelines, prior to 
undertaking the additional searches (see Figure 1). Two researchers independently extracted 
data from included studies. When data were not available in the published article, the study 
authors were contacted and asked to provide them.  Two researchers, using the Cochrane 
Collaboration’s risk of bias rating tool (Higgins & Green, 2011), rated the quality of all 
included studies for which data were available1.  All available data addressing specific 
scoping questions were meta-analyzed using Revman Version 5.3 software (2011).  
The evidence for each of the scoping questions was summarized and its quality 
assessed using the Grading of Recommendations Assessment, Development and Evaluation 
(GRADE)2 system.  The evidence summaries and quality assessments were then used to 
generate draft recommendations using the algorithm described below.  The draft 
recommendations were posted on the ISTSS website during August and September 2018 for 
a period of consultation by ISTSS members.  Feedback from ISTSS members was reviewed 
and incorporated into the final recommendations. Final recommendations were presented to 
and approved by the ISTSS Board in October 2018, and presented publicly at the annual 
ISTSS meeting in November 2018. 
                                                        
1 The Cochrane Collaboration’s risk of bias criteria2 determine low, uncertain or high risk ratings for: Random sequence 
generation (selection bias); Allocation concealment (selection bias); Blinding of participants and personnel (performance 
bias); Blinding of outcome assessment (detection bias); Incomplete outcome data (attrition bias); Selective reporting 
(reporting bias); and Other bias.  
2 GRADE Working Group Grades of Evidence5 
High quality: Further research is very unlikely to change our confide ce in the estimate of effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may 
change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is 
likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
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Definition of Clinical Importance 
In order to generate recommendations from the results of the meta-analyses, the 
committee developed a definition of clinical importance shown in Figure 2 following 
consultation with ISTSS members and the ISTSS Board. 
Recommendation Setting 
An algorithm was developed to allow the systematic and objective agreement of 
recommendations after scrutiny of the meta-analyses pertaining to individual scoping 
questions. Consideration was given to magnitude of change, strength/quality of evidence and 
any other important factors (e.g., adverse effects).  Five different levels of recommendation 
were possible as shown in Figure 3.  It was agreed that having five different levels of 
recommendation would facilitate decision-making with respect to clinical care and also future 
research.  For example, the “emerging evidence” recommendation was included to identify 
novel interventions, including novel interventions, that require further evaluation and may 
hold promise for the future.  
Results 
The searches identified 5,500 potential new studies and scrutiny of these and studies 
included in existing reviews resulted in 361 RCTs fulfilling the criteria for inclusion in the 
meta-analyses that were undertaken. Of these studies, 327 (91%) provided data that were 
included in the meta-analyses and were used to generate evidence summaries. Two hundred 
and eight meta-analyses were completed and used to generate 125 individual 
recommendations (24 for children and adolescents, and 101 for adults).  There were 8 Strong,
8 Standard, 5 Low Effect, 26 Emerging Evidence, and 78 Insufficient Evidence to 
Recommend recommendations.  There was only one recommendation against providing a 
specific intervention (“Individual Psychological Debriefing within the first three months of a 
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traumatic event has emerging evidence of increasing the risk of clinically relevant post-
traumatic stress symptoms in children and adolescents”). Figure 4 provides an example of the 
recommendations made. 
 
Complex PTSD Position Papers 
The position papers on Complex PTSD (CPTSD) for adults and children/adolescents 
note previous challenges, including lack of clarity in the characterization of complex 
presentations of PTSD and consequently lack of persuasive evidence regarding the 
phenomenon of CPTSD, its assessment and its treatment (e.g. Karatzias et al., 2017; Shevlin 
et al., 2018).  The papers introduce the ICD-11 diagnosis of CPTSD, emphasizing that the 
diagnosis is made on the basis of the symptom profile and not the type of trauma (Cloitre et 
al., 2013). In children and adolescents, the importance of developmental considerations when 
assessing symptoms of CPTSD is emphasized.   
It is noted that some existing treatments have been shown to reduce the symptoms of 
CPTSD with some evidence that scores remain higher for individuals likely to have CPTSD 
than for those with a diagnosis of ICD-11 PTSD (e.g., Sachser et al., 2016). The papers call 
for further research to determine optimal treatments for CPTSD.  Possible approaches include 
increased dosing and/or adaptation of existing treatments, sequencing of treatment 
components, booster sessions, the addition of other, as yet, unspecified components and more 
flexible implementation of problem specific treatment modules using a personalized 
approach.  Innovations in research design and treatment formulation provide the opportunity 
to continue to improve outcomes for adults and children/adolescents with CPTSD. 
The CPTSD position papers have now replaced the ISTSS’s previously published expert 
consensus treatment guidelines for complex PTSD (Cloitre et al, 2012).  
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Discussion 
The ISTSS Guidelines for the Prevention and Treatment of PTSD provide 125 
recommendations generated through syntheses of current RCT evidence. These 
recommendations address 20 carefully selected scoping questions.  The method and process 
adopted for this effort adhere to internationally recommended standards (IoM, 2011) and 
compare favorably with those used to develop other recent and commonly followed 
guidelines for the prevention and treatment of PTSD (APA, 2017; VA/DoD, 2018; NICE, 
2018; Phoenix Australia, 2013). Notably, as a result of strict adherence to the internationally 
recommended standards, this version of the guidelines reflects a substantial change in 
methodology compared to the two earlier guidelines produced by ISTSS.  It is hoped that the 
new ISTSS Guidelines will be widely adopted across the world, shape clinical service 
provision for those exposed to traumatic events, inform the research agenda, and foster 
development of the field. 
The review revealed a significant growth of RCT evidence in recent years. This has 
resulted in a strengthening of recommendations relative to earlier guidelines for certain 
interventions such as CBT-T (child), CBT-T (caregiver and child) and EMDR for the 
treatment of PTSD in children and adolescents. The additional RCTs also provided the ability 
to consider different forms of CBT- separately and, consequently, to recommend some 
forms (e.g. CPT, CT-PTSD and PE) more strongly than others (e.g. Group CBT-T, NET and 
BEPP). The emergence of interventions that may not be as effective as the strongest 
interventions for PTSD but, nevertheless, have the potential to make a real difference to 
people with PTSD (e.g. facilitated internet-based CBT-T, PCT, and some medications) and 
allow choice in treatment modalities is a major step forward. 
The inclusion of an “emerging evidence” recommendation category allowed 
recognition of a number of novel and innovative prevention and treatment approaches (e.g., 
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neurofeedback and yoga), absent from previous guidelines.  It is important to remember that 
emerging evidence recommendations were usually based on one or two RCTs with very low 
GRADE ratings.  It is likely that some will develop into effective and strongly recommended 
interventions with robust evidence of effect and that others will not fulfill their initial promise 
once further research is undertaken.  As such, these can be considered as potential priority 
candidate interventions for further research and should not be considered as front-line 
approaches for the prevention and treatment of PTSD.  Still, the Committee saw value in 
highlighting this group of interventions above those with insufficient evidence to make any 
recommendation, notwithstanding the important adage that absence of evidence is not 
absence of effect.   
Strengths, Limitations and Interpretation 
Key strengths of the ISTSS Guidelines are the transparency and replicability of the 
process used. The Committee established a priori agreement of key elements of the review 
and recommendation processes: scoping questions, inclusion/exclusion criteria for papers, 
definition of clinical importance, and a recommendation generation algorithm.  Using a 
rigorous methodology across the varied scoping questions reduced the risk of inconsistency 
and conscious or unconscious bias of committee members impacting the recommendations 
made. In common with all prevention and treatment guidelines, there are also a number of 
limitations and it is important that these are taken into account when interpreting and before 
implementing the recommendations. 
The selection of the guideline committee is a potential source of bias (IoM, 2011).  
All  members of the ISTSS Guidelines Committee declared conflicts of interest, primarily as a 
result of allegiance to different psychological interventions. These were transparently 
declared but may have influenced outcomes.  It has been argued that including members with 
conflicts of interest should be avoided or minimized (Shekelle, 2018; IoM, 2011).   Having a 
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committee with no conflict of interest risks having a committee without sufficient knowledge 
and expertise.  The ISTSS Board was keen to include individuals with expertise (and, 
consequently, potential conflicts of interest) in various approaches to the prevention and 
treatment of PTSD in adults, children and adolescents and also expertise in guideline 
development, systematic reviews and meta-analysis.   
Only including RCTs can be seen as a strength but also a limitation as it risks relying 
too heavily on, at times, low quality RCTs whilst ignoring other possible sources of evidence 
(Bothwell et al., 2016; Sackett et al., 1996).  Incorporating evidence from other sources such 
as large observational cohort studies, non-randomized controlled studies such as effectiveness 
studies and “evidence from practice” could, potentially, contribute to a more accurate overall 
assessment of the effectiveness of a particular intervention and would allow consideration of 
effect from different perspectives.  Unfortunately, this approach could also risk diluting 
higher quality sources of evidence with weaker ones and drawing inferences without 
sufficient information to do so.  Guideline developers are increasingly acknowledging this 
dilemma and recognize that RCT evidence is not the only source of helpful knowledge 
(NICE, 2018b).  Irrespective of the sources of evidence used, recognition of the importance 
of other, real-world factors that may influence the adoption and implementation of 
recommendations is very important to understanding the real world success of these 
treatments.  The practice implications of the ISTSS Guidelines’ recommendations will be the 
primary focus of the third edition of the Effective Treatments for PTSD book. 
Another limitation is that only 20 scoping questions were addressed by the present 
reviews.  This number reflected the Committee’s effort to balance the breadth of pertinent 
topics, the time and resources available to conduct the reviews, and the availability of 
published RCTs to address the questions. There are many other important questions 
concerning the prevention and treatment of PTSD that were not answered by the ISTSS 
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Guidelines.  These include preventative interventions for high risk occupations such as 
military and first responders delivered prior to exposure, comorbidity with other conditions, 
especially when PTSD is not the primary diagnosis, prevention beyond 3 months after 
traumatic events (e.g., there has been a lot of work from schools in traumatized populations 
trying to prevent the development of PTSD months and years after traumatic events 
occurred), the long term effects of interventions, relative efficacy of pharmacological and 
psychological treatments, sequencing of treatment, augmentation treatment and drug-assisted 
psychological treatment.   
Another issue encountered was that several high-quality RCTs were designed in a 
way that did not allow them to be included in the meta-analyses.  For example, in the case of 
CPT, several methodologically strong studies did not compare CPT against usual treatment or 
waitlist control but compared different modes of delivery of CPT against each other (Morland 
et al., 2015) or used a novel RCT methodology that precluded inclusion in our meta-analyses 
(Galovski & Blain, 2012). Additionally, the significant number of CPT effectiveness studies 
demonstrating its applicability to a broad and diverse range of clinical populations and 
settings, while providing potentially very important information for clinicians, service 
planners and policy makers, were not included due to failure to meet the RCT specifications. 
This may account for CPT having less evidence of efficacy against waitlist/usual care than 
other established treatments of PTSD that received a strong recommendation (e.g. EMDR 
and PE).  Our algorithm did, however, allow a strong recommendation to be made for CPT, 
on the basis of equivalence in head to head RCTs versus another strongly recommended 
treatment.  The experience of the Committee with CPT supports the need for more innovative 
methodological approaches to the development of guidelines to include other sources of high 
quality evidence.   
ISTSS Guidelines for PTSD  13 
 
 
Even among the RCTs included in the analyses, differences in the methodology 
employed varied between studies and may have impacted meta-analytic results and their 
interpretation. Issues encountered included the use of different measures of PTSD 
symptomatology, different treatment populations, different approaches to calculating means, 
and different ways of dealing with missing data. The Committee made an a priori decision to 
use data in meta-analyses from as many eligible studies as possible. This meant including 
self-report data in the absence of clinician-reported data and completer-only data in the 
absence of intention-to-treat data.  The inclusion of completer-only data may have 
contributed to bias and it is important to note this when interpreting the results. 
Metaphorically, we compared apples of different varieties in individual meta-analyses but did 
not compare apples with pears. 
 Before meta-analyses were performed, the Committee considered and then defined 
what level of effect represented a clinically important difference and incorporated this into an 
a priori agreed algorithm to determine different levels of recommendation.  This is a major 
strength of the ISTSS Guidelines and adheres to recommended standards (GRADE) but 
requires judgment calls that inevitably influence the recommendations made. For example, 
the decision to require an effect size for placebo-controlled trials 50% that of waitlist/usual 
care trials (0.8 versus 0.4), although informed by previous guideline development work and 
expert opinion, may or may not be optimal.  It is almost impossible to argue against having a 
reduced threshold for placebo-controlled trials but the magnitude of that reduction is open to 
debate. Similarly, the effect size threshold for active treatment control comparisons was 0.2 
as it was agreed that active treatment controls were likely to be more effective than placebo.  
Another decision, in line with many other guidelines, was to group wait list and usual care 
control conditions.  Careful scrutiny of usual care conditions reveals a variety of approaches 
ranging from minimal care to more extensive intervention with the potential to influence 
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outcomes quite significantly and possibly cause some interventions to appear less effective 
than they actually are. 
One measure of the effectiveness of these a priori decisions is that only five 
recommendation decisions (all concerning treatment) required the achievement of consensus 
through ISTSS Guidelines Committee discussion; the algorithm generated the other 120 
recommendations.  This 24:1 ratio is a strength of the methodological approach; strict 
adherence to a priori rules is not only relatively unique in PTSD guideline development but 
also likely to have reduced risk of bias due to specific views of Committee members. 
The five more subjective committee decisions (upgrading CPT in adults, and EMDR 
and CBT-TF for children and adolescents, and downgrading neurofeedback and TMS in 
adults) were made as a result of the a priori rules triggering reconsideration of algorithm-
generated recommendations when a degree of doubt was present. Allowing any 
reconsideration clearly introduces the risk of bias, but this has to be balanced against 
unintended consequences of an algorithm that, although developed a priori, has the potential 
to generate spurious results.  A different committee may have made different decisions, but 
those made were carefully deliberated over before achieving consensus, and importantly 
occurred through an explicit and transparent process. 
The ISTSS recommendations are based on the agreed primary outcome of PTSD 
symptomatology post-treatment.  This was usually the primary outcome for included studies 
but risks ignoring or underplaying other important outcomes.  Depression, anxiety, substance 
use, overall functioning, quality of life and longer-term follow-up with respect to PTSD were 
not considered, yet could have altered the recommendations if they were and have done so in 
other guidelines.  For example, NICE recommends against psychological debriefing for 
adults on the basis of evidence of harm at longer-term follow-up (NCCMH, 2005); the ISTSS 
Guidelines concluded that there is insufficient evidence to recommend either way.   
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Significant clinical and statistical heterogeneity within the meta-analyses undertaken 
complicates interpretation, not least with respect to reliability and generalizability of some of 
the findings (Melsen et al., 2014). For example, the emerging evidence recommendation for 
hydrocortisone as an early pharmacological treatment following traumatic events in adults is 
based on RCTs of hospitalized inpatients following major surgery. It is very debatable as to 
how generalizable this finding would be to other populations and hydrocortisone could not be 
recommended for routine use following traumatic events with the evidence available at 
present. The key implication of the emerging evidence for hydrocortisone recommendation is 
that it is a strong candidate for further research to determine its potential to prevent PTSD. 
The studies included in the meta-analyses covered heterogeneous settings and 
populations.  The majority of included studies were conducted in higher income settings and 
caution is required when applying the results to low and middle-income settings.  It cannot be 
assumed that interventions are always transferable, reassuringly, however, research has found 
that a number of effective treatments for PTSD are effective in different settings across the 
world (Bass et al., 2013).   Whatever the heterogeneity, it is likely that some adaptations to 
processes adopted in research studies, based on local service configuration, will be needed to 
implement recommendations in an acceptable, effective and sustainable manner.  These and 
other factors, for example, variation in therapist competence, differences between grouped 
interventions and the number of sessions/dosage delivered, the possibility of interventions 
causing adverse effects and being less tolerated by some individuals than others, means that 
care should be taken in interpreting recommendations and determining their implications for 
clinical practice.   
Whatever the level of recommendation, a specific intervention is unlikely to be 
appropriate for all people with PTSD.  Interventions should only be delivered after a 
thorough assessment of an individual’s needs and, where possible, a discussion between the 
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individual (and caregivers) and therapist with clear information about the evidence base, 
potential benefits and risks to allow informed decision-making and the development of a co-
determined intervention plan.  These issues will be covered in detail in the Effective 
Treatments for PTSD book.  
Conclusion 
The ISTSS Guidelines represent a high-quality addition to the existing guideline 
recommendations available to clinicians.  Like all guidelines, the ISTSS Guidelines should be 
used with appropriate caution; they represent a tool to aid the prevention and treatment of 
PTSD rather than a document that mandates specific approaches.  The ISTSS Guidelines 
should stimulate research to improve the effectiveness of interventions in the future and also 
stimulate work to improve the methodology of guideline development.  It is hoped they will 
support the dissemination and implementation of evidence-based practices to reduce the 
impact of traumatic stress globally. Further work to develop appropriate public-facing 
materials, including decision aids, to facilitate this is underway. 
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 Any randomized controlled trial (including cluster and cross-over trials) evaluating the 
efficacy of interventions aimed at preventing (within 3 months of the traumatic event), 
treating or reducing symptoms of PTSD. 
 Study participants have been exposed to a traumatic event as specified by PTSD 
diagnostic criteria for DSM-III, DSM-III-R, DSM-IV, DSM-5, ICD-9, ICD-10 or ICD-11.  
 Eligible comparator interventions for psychosocial interventions: waitlist, treatment as 
usual, symptom monitoring, repeated assessment, other minimal attention control 
group or an alternative psychological treatment. 
 Eligible comparator interventions for pharmacological interventions: placebo, other 
pharmacological or psychosocial intervention. 
 The RCT is not solely a dismantling study  
 Study outcomes include a standardized measure of PTSD symptoms (either clinician-
administered or self-report). 
 No restriction on the basis of severity of PTSD symptoms or the type of traumatic 
event. 
 Individual, group and couple interventions. 
 No minimum sample size. 
 Only studies published in English. 
 Unpublished studies eligible. 
 
For early intervention studies only  
 Intervention begins no later than 3 months after the traumatic event. 
 Intervention is not provided pre-trauma. 
For treatment studies only 
 For adults, at least 70% of participants required to be diagnosed with PTSD 
according to DSM or ICD criteria by means of a structured interview or diagnosis by a 
clinician. 
 For children and adolescents, at least 70% diagnosed with partial or full DSM or ICD 
PTSD by means of a structured interview or diagnosis by a clinician (partial PTSD is 
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defined as at least one symptom per cluster and presence of impairment), or score 
above a standard cut-off of a validated self-report measure. 
 Duration of PTSD symptoms required to be three months or more. 
 No restrictions on the basis of comorbidity, but PTSD required to be the primary 
diagnosis. 
Figure 1. Inclusion criteria for included studies.  
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 PTSD symptom change was the primary outcome measure and other outcomes (e.g., 
diagnosis, functioning, other symptom change, tolerability) were considered as 
secondary outcome measures. 
 The clinically important definition was based on both magnitude of change and 
strength/quality of evidence. 
 An intervention delivered three or more months after the traumatic event had to 
demonstrate an effect size, calculated as the standardized mean difference (SMD), 
for continuous outcomes of >0.8 (<0.65 relative risk for binary outcomes) for wait list 
control comparisons, >0.5 for attention control comparisons (no meaningful 
treatment, but same dosage of time/same number of sessions with a therapist), >0.4 
for placebo control comparisons and >0.2 for active treatment control comparisons. 
 To be rated clinically important, an early intervention had to demonstrate an effect 
size for continuous outcomes of >0.5 for wait list control comparisons (< 0.8 relative 
risk for binary outcomes). 
 If there was only one RCT, an intervention was not normally recommended as 
clinically important. Non-inferiority RCT evidence alone was not enough to 
recommend an intervention as clinically important.   
 Unless there was a GRADE quality of evidence rating of high or moderate, 
consideration was given to downgrading the strength of recommendation made with 
respect to clinical importance. 
 The primary analysis for a particular question included data from all included studies.  
When available, this was clinician rated; when not, self-report was included.  In 
addition, an analysis was also considered of only studies with clinician rated data.  
The combination of these two analyses was considered along with the GRADE 
ratings and risk of bias ratings to determine the strength of recommendation.   
 The 95% confidence interval range had to completely exclude the thresholds for the 
strongest level of recommendation (e.g. lower confidence interval of >0.8 for waiting 
list control comparisons of treatments). 
Figure 2. Definition of clinical importance.  
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 ‘Strong’ - interventions with at least reasonable quality of evidence and the highest 
certainty of effect.   
  ‘Standard’ - at least reasonable quality of evidence and lower certainty of effect.   
  ‘Intervention with Low Effect’ - at least reasonable quality of evidence and high 
certainty of a low level of effect.   
 ‘Emerging Evidence’ - lower quality of evidence and/or certainty of effect.   
  ‘Insufficient Evidence to Recommend’ - absence of evidence of effectiveness or 
ineffectiveness. 
Figure 3. Levels of recommendation. 
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Strong Recommendation - Cognitive Processing Therapy, Cognitive Therapy, EMDR, 
Individual CBT with a Trauma Focus (undifferentiated), and Prolonged Exposure are 
recommended for the treatment of adults with PTSD. 
 
Standard Recommendation - CBT without a Trauma Focus, Group CBT with a Trauma 
Focus, Guided Internet-based CBT with a Trauma Focus, Narrative Exposure Therapy, 
and Present Centered Therapy are recommended for the treatment of adults with PTSD. 
 
Interventions with Emerging Evidence - Couples CBT with a Trauma Focus, Group and 
Individual CBT with a Trauma Focus, Reconsolidation of Traumatic Memories, Single 
Session CBT, Written Exposure Therapy, and Virtual Reality Therapy have emerging 
evidence of efficacy for the treatment of adults with PTSD. 
 
Insufficient Evidence to Recommend - There is insufficient evidence to recommend Brief 
Eclectic Psychotherapy for PTSD, Dialogical Exposure Therapy, Emotional Freedom 
Techniques, Group Interpersonal Therapy, Group Stabilizing Treatment, Group 
Supportive Counseling, Interpersonal Psychotherapy, Observed and Experimental 
Integration, Psychodynamic Psychotherapy, Psychoeducation, Relaxation Training, 
REM Desensitization, or Supportive Counseling for the treatment of adults with PTSD. 
Figure 4. Recommendations for psychological treatment of PTSD in adults. Summary of 
relevant scoping questions: For adults with PTSD, do psychological treatments when 
compared to treatment as usual, waiting list, no treatment or other psychological treatments 
result in a clinically important reduction of symptoms, improved functioning/ quality of life, 
presence of disorder, or adverse effects? 
 
